Lecrolyn Sine (Sodium Cromoglicate)

Sodium cromoglicate stabilizes mast cells in the conjunctiva, preventing them from releasing histamine, leukotrienes, and other inflammatory mediators. By blocking this degranulation process, the drug reduces the cascade of allergic inflammation that causes the typical symptoms of ocular allergy.

The dosing regimen for Lecrolyn Sine is determined by the prescribing clinician based on the severity of the allergic eye condition and patient-specific factors. Healthcare providers typically instruct patients on the number of drops per eye and the frequency of administration.

Safety data for sodium cromoglicate in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare professional before using Lecrolyn Sine.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity of Lecrolyn Sine. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Lecrolyn Sine (sodium cromoglicate) is a mast cell stabilizer, whereas many alternative eye drops are antihistamines or combination antihistamine‑mast cell stabilizers (e.g., olopatadine). Sodium cromoglicate primarily prevents mast‑cell degranulation, offering a prophylactic approach, while antihistamines provide rapid symptom relief. Choice of therapy depends on patient response, severity of symptoms, and physician preference.

Lecrolyn Sine should be stored at room temperature, below 25 °C, in its original packaging. Keep the container tightly closed, protect it from direct light and moisture, and discard any remaining solution after the recommended period once opened to maintain sterility.

Lecrolyn Sine is administered as eye drops. The patient should wash their hands, tilt the head back, gently pull down the lower eyelid, and instill the prescribed number of drops into the conjunctival sac. After dosing, keep the eyes closed for a few seconds to allow absorption and avoid blinking excessively.

While generally well tolerated, serious risks include severe allergic reactions such as angioedema of the eyelid, persistent eye pain, sudden loss of visual acuity, corneal ulceration, or anaphylaxis. Patients experiencing any of these symptoms should seek immediate medical attention.

Lecrolyn Sine should not be used by individuals with a known hypersensitivity to sodium cromoglicate or any of the formulation excipients. Patients with active ocular infections should defer use until the infection is resolved, and contact lens wearers should follow specific instructions regarding lens removal and reinsertion.